1.
Huang Y, de Leval L, Gaulard P. Molecular underpinning of extranodal NK/T-cell lymphoma . Best Pract Res Clin Haematol. 2013; ; 26 : :57.–74.
2.
Murata K, Yamada Y. The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL . Int Rev Immunol. 2007; ; 26 : :249.–268.
3.
Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia . Front Microbiol. 2012; ; 3 : :334..
4.
William BM, Armitage JO. International analysis of the frequency and outcomes of NK/T-cell lymphomas . Best Pract Res Clin Haematol. 2013; ; 26 : :23.–32.
5.
Lin CW, Lee WH, Chang CL, et al. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas . Am J Pathol. 2001; ; 159 : :1671.–1679.
6.
Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro . Leukemia. 2011; ; 25 : :348.–358.
7.
Chiang AK, Chan AC, Srivastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage . Int J Cancer. 1997; ; 73 : :332.–338.
8.
Iqbal J, Liu Z, Deffenbacher K, et al. Gene expression profiling in lymphoma diagnosis and management . Best Pract Res Clin Haematol. 2009; ; 22 : :191.–210.
9.
Iqbal J, Kucuk C, Deleeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies . Leukemia. 2009; ; 23 : :1139.–1151.
10.
Huang Y, de Reyniès A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type . Blood. 2010; ; 115 : :1226.–1237.
11.
Ng SB, Selvarajan V, Huang G, et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling . J Pathol. 2011; ; 223 : :496.–510.
12.
Coppo P, Gouilleux-Gruart V, Huang Y, et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma . Leukemia. 2009; ; 23 : :1667.–1678.
13.
Shtilbans V, Wu M, Burstein DE. Current overview of the role of Akt in cancer studies via applied immunohistochemistry . Ann Diagn Pathol. 2008; ; 12 : :153.–160.
14.
Jørgensen JM, Sørensen FB, Bendix K, et al. Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas . Leuk Lymphoma. 2009; ; 50 : :1647.–1660.
15.
Bischoff JR, Plowman GD. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis . Trends Cell Biol. 1999; ; 9 : :454.–459.
16.
Katayama H, Sasai K, Kawai H, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 . Nat Genet. 2004; ; 36 : :55.–62.
17.
Nakashima Y, Tagawa H, Suzuki R, et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type . Genes Chromosomes Cancer. 2005; ; 44 : :247.–255.
18.
Siu LL, Chan V, Chan JK, et al. Consistent patterns of allelic loss in natural killer cell lymphoma . Am J Pathol. 2000; ; 157 : :1803.–1809.
19.
Siu LL, Wong KF, Chan JK, et al. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations . Am J Pathol. 1999; ; 155 : :1419.–1425.
20.
Taborelli M, Tibiletti MG, Martin V, et al. Chromosome band 6q deletion pattern in malignant lymphomas . Cancer Genet Cytogenet. 2006; ; 165 : :106.–113.
21.
Ko YH, Choi KE, Han JH, et al. Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma . Cytometry. 2001; ; 46 : :85.–91.
22.
Sun HS, Su I-J, Lin Y-C, et al. A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma . Br J Haematol. 2003; ; 122 : :590.–599.
23.
Küçük C, Iqbal J, Hu X, et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies . Proc Natl Acad Sci USA. 2011; ; 108 : :20119.–20124.
24.
Karube K, Nakagawa M, Tsuzuki S, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses . Blood. 2011; ; 118 : :3195.–3204.
25.
Küçük C, Hu X, Iqbal J, et al. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms . Am J Pathol. 2013; ; 182 : :49.–55.
26.
Anglesio MS, Evdokimova V, Melnyk N, et al. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms’ tumor versus normal kidney . Hum Mol Genet. 2004; ; 13 : :2061.–2074.
27.
Zhang L, Anglesio MS, O’Sullivan M, et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers . Nat Med. 2007; ; 13 : :1060.–1069.
28.
Thelander EF, Ichimura K, Corcoran M, et al. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia . Leuk Lymphoma. 2008; ; 49 : :477.–487.
29.
Sakata M, Kitamura YH, Sakuraba K, et al. Methylation of HACE1 in gastric carcinoma . Anticancer Res. 2009; ; 29 : :2231.–2233.
30.
Hibi K, Sakata M, Sakuraba K, et al. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer . Anticancer Res. 2008; ; 28 : :1581.–1584.
31.
Koo GC, Tan SY, Tang T, et al. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma . Cancer Discov. 2012; ; 2 : :591.–597.
32.
Bouchekioua A, Scourzic L, de Wever O, et al. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma . Leukemia. 2014; ; 28 : :338.–348.
33.
Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia . Blood. 2012; ; 120 : :3048.–3057.
34.
Koskela HLM, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia . N Engl J Med. 2012; ; 366 : :1905.–1913.
35.
Küçük C, Jiang B, Hu X, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells . Nat Commun. 2015; ; 6 : :6025..
36.
Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma . Nat Genet. 2015; ; 47 : :1061.–1066.
37.
Shen L, Liang ACT, Lu L, et al. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma . Am J Pathol. 2002; ; 161 : :2123.–2131.
38.
Takakuwa T, Dong Z, Nakatsuka S, et al. Frequent mutations of Fas gene in nasal NK/T cell lymphoma . Oncogene. 2002; ; 21 : :4702.–4705.
39.
Takahara M, Kishibe K, Bandoh N, et al. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido . Japan. Hum Pathol. 2004; ; 35 : :86.–95.
40.
Hoshida Y, Hongyo T, Jia X, et al. Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK/T cell lymphoma in northeast district of China . Cancer Sci. 2003; ; 94 : :297.–301.
41.
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma study group (1984–87) . Br J Haematol. 1991; ; 79 : :428.–437.
42.
Tsukasaki K, Tobinai K. Biology and treatment of HTLV-1 associated T-cell lymphomas . Best Pract Res Clin Haematol. 2013; ; 26 : :3.–14.
43.
Yasunaga J, Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis . Int J Hematol. 2011; ; 94 : :435.–442.
44.
Hasegawa H, Sawa H, Lewis MJ, et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I . Nat Med. 2006; ; 12 : :466.–472.
45.
Ohsugi T, Kumasaka T, Okada S, et al. The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells . Nat Med. 2007; ; 13 : :527.–528.
46.
Suzuki T, Kitao S, Matsushime H, et al. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4 . EMBO J. 1996; ; 15 : :1607.–1614.
47.
Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1 . Oncogene. 1996; ; 12 : :1645.–1652.
48.
Neuveut C, Low KG, Maldarelli F, et al. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb . Mol Cell Biol. 1998; ; 18 : :3620.–3632.
49.
Schmitt I, Rosin O, Rohwer P, et al. Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein . J Virol. 1998; ; 72 : :633.–640.
50.
Suzuki T, Narita T, Uchida-Toita M, et al. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms . Virology. 1999; ; 259 : :384.–391.
51.
Haller K, Wu Y, Derow E, et al. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein . Mol Cell Biol. 2002; ; 22 : :3327.–3338.
52.
Cheng H, Ren T, Sun S. New insight into the oncogenic mechanism of the retroviral oncoprotein Tax . Protein Cell. 2012; ; 3 : :581.–589.
53.
Grassmann R, Aboud M, Jeang K-T. Molecular mechanisms of cellular transformation by HTLV-1 Tax . Oncogene. 2005; ; 24 : :5976.–5985.
54.
Arnulf B, Villemain A, Nicot C, et al. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis . Blood. 2002; ; 100 : :4129.–4138.
55.
El-Sabban ME, Merhi RA, Haidar HA, et al. Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells . Blood. 2002; ; 99 : :3383.–3389.
56.
Takeda S, Maeda M, Morikawa S, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells . Int J Cancer. 2004; ; 109 : :559.–567.
57.
Koiwa T, Hamano-Usami A, Ishida T, et al. 5’-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo . J Virol. 2002; ; 76 : :9389.–9397.
58.
Furukawa Y, Kubota R, Tara M, et al. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia . Blood. 2001; ; 97 : :987.–993.
59.
Arnulf B, Thorel M, Poirot Y, et al. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma . Leukemia. 2004; ; 18 : :126.–132.
60.
Miyazaki M, Yasunaga J-I, Taniguchi Y, et al. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5’ long terminal repeat during oncogenesis . J Virol. 2007; ; 81 : :5714.–5723.
61.
Satou Y, Yasunaga J, Yoshida M, et al. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells . Proc Natl Acad Sci USA. 2006; ; 103 : :720.–725.
62.
Arnold J, Yamamoto B, Li M, et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1 . Blood. 2006; ; 107 : :3976.–3982.
63.
Arnold J, Zimmerman B, Li M, et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation . Blood. 2008; ; 112 : :3788.–3797.
64.
Matsuoka M, Yasunaga J. Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor . Curr Opin Virol. 2013; ; 3 : :684.–691.
65.
Zhao T, Yasunaga J, Satou Y, et al. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB . Blood. 2009; ; 113 : :2755.–2764.
66.
Satou Y, Yasunaga J-I, Zhao T, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo . PLoS Pathog. 2011; ; 7 : :e1001274..
67.
Tsukasaki K, Krebs J, Nagai K, et al. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course . Blood. 2001; ; 97 : :3875.–3881.
68.
Oshiro A, Tagawa H, Ohshima K, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma . Blood. 2006; ; 107 : :4500.–4507.
69.
Uchida T, Kinoshita T, Watanabe T, et al. The CDKN2 gene alterations in various types of adult T-cell leukaemia . Br J Haematol. 1996; ; 94 : :665.–670.
70.
Yamada Y, Hatta Y, Murata K, et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia . J Clin Oncol. 1997; ; 15 : :1778.–1785.
71.
Nosaka K, Maeda M, Tamiya S, et al. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia . Cancer Res. 2000; ; 60 : :1043.–1048.
72.
Tawara M, Hogerzeil SJ, Yamada Y, et al. Impact of p53 aberration on the progression of adult T-cell leukemia/lymphoma . Cancer Lett. 2006; ; 234 : :249.–255.
73.
Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5; 14)(q35; q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia . Leukemia. 2001; ; 15 : :1495.–1504.
74.
Su X-Y, Della-Valle V, Andre-Schmutz I, et al. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5; 14)(q35;q32) . Blood. 2006; ; 108 : :4198.–4201.
75.
Li L, Zhang JA, Dose M, et al. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression . Blood. 2013; ; 122 : :902.–911.
76.
Gutierrez A, Kentsis A, Sanda T, et al. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia . Blood. 2011; ; 118 : :4169.–4173.
77.
Kurosawa N, Fujimoto R, Ozawa T, et al. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma . PloS One. 2013; ; 8 : :e55147..
78.
Fujimoto R, Ozawa T, Itoyama T, et al. HELIOS-BCL11B fusion gene involvement in a t(2;14) (q34;q32) in an adult T-cell leukemia patient . Cancer Genet. 2012; ; 205 : :356.–364.
79.
Pancewicz J, Taylor JM, Datta A, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia . Proc Natl Acad Sci USA. 2010; ; 107 : :16619.–16624.
80.
Nakagawa M, Schmitz R, Xiao W, et al. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma . J Exp Med. 2014; ; 211 : :2497.–2505.
81.
Yamamoto K, Utsunomiya A, Tobinai K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma . J Clin Oncol. 2010; ; 28 : :1591.–1598.
82.
Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study . J Clin Oncol. 2012; ; 30 : :837.–842.
83.
Taniguchi A, Nemoto Y, Yokoyama A, et al. Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia . Int J Cancer. 2008; ; 123 : :1824.–1831.
84.
Yang Y, Takeuchi S, Tsukasaki K, et al. Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma . Leuk Res. 2005; ; 29 : :47.–51.
85.
Sasaki D, Imaizumi Y, Hasegawa H, et al. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy . Haematologica. 2011; ; 96 : :712.–719.
86.
Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers . Cancer Cell. 2012; ; 21 : :121.–135.
87.
Kataoka K, Nagata Y, Kitanaka A,
et al. Integrated molecular analysis of adult T cell leukemia/lymphoma .
Nat Genet. 2015 ; Oct 5. doi:
10.1038/ng.3415.
88.
Yamazaki J, Mizukami T, Takizawa K, et al. Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma . Blood. 2009; ; 114 : :2709.–2720.
89.
Nagai Y, Kawahara M, Hishizawa M, et al. T memory stem cells are the hierarchical apex of adult T-cell leukemia . Blood. 2015; ; 125 : :3527.–3535.
90.
Chandesris M-O, Malamut G, Verkarre V, et al. Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives . Gastroentérologie Clin Biol. 2010; ; 34 : :590.–605.
91.
Spencer J, Cerf-Bensussan N, Jarry A, et al. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes . Am J Pathol. 1988; ; 132 : :1.–5.
92.
Hüe S, Mention J-J, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease . Immunity. 2004; ; 21 : :367.–377.
93.
Roshan B, Leffler DA, Jamma S, et al. The incidence and clinical spectrum of refractory celiac disease in a north american referral center . Am J Gastroenterol. 2011; ; 106 : :923.–928.
94.
Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma . French Coeliac Disease Study Group. Lancet. 2000; ; 356 : :203.–208.
95.
Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II . Gastroenterology. 2009; ; 136 : :81.–90.
96.
Al-Toma A, Verbeek WHM, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience . Gut. 2007; ; 56 : :1373.–1378.
97.
De Mascarel A, Belleannée G, Stanislas S, et al. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype . Am J Surg Pathol. 2008; ; 32 : :744.–751.
98.
Malamut G, Meresse B, Cellier C, et al. Refractory celiac disease: from bench to bedside . Semin Immunopathol. 2012; ; 34 : :601.–613.
99.
Verkarre V, Romana SP, Cellier C, et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue . Gastroenterology. 2003; ; 125 : :40.–46.
100.
Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes . Gastroenterology. 2007; ; 132 : :1902.–1911.
101.
Zettl A, deLeeuw R, Haralambieva E, et al. Enteropathy-type T-cell lymphoma . Am J Clin Pathol. 2007; ; 127 : :701.–706.
102.
Obermann EC, Diss TC, Hamoudi RA, et al. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma . J Pathol. 2004; ; 202 : :252.–262.
103.
Cejkova P, Zettl A, Baumgärtner AK, et al. Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma . Virchows Arch Int J Pathol. 2005; ; 446 : :416.–420.
104.
Quintanilla-Martinez L, Kremer M, Keller G, et al. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease . Am J Pathol. 2001; ; 159 : :2095.–2105.
105.
Hongyo T, Hoshida Y, Nakatsuka SI, et al. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan . Oncol Rep. 2005; ; 13 : :265.–271.
106.
Siu LLP, Chan JKC, Wong KF, et al. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved . Am J Pathol. 2002; ; 160 : :59.–66.
107.
Kawamata N, Inagaki N, Mizumura S, et al. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders . Eur J Haematol. 2005; ; 74 : :424.–429.
108.
Siu LLP, Chan JKC, Wong KF, et al. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas . Br J Haematol. 2003; ; 122 : :70.–77.
109.
Hongyo T, Li T, Syaifudin M, et al. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan . Cancer Res. 2000; ; 60 : :2345.–2347.
110.
Couronné L, Bastard C, Gaulard P, Hermine O, Bernard O. Aspects moléculaires des lymphomes T périphériques (1) : lymphome T angio-immunoblastique, lymphome T périphérique non spécifié et lymphome anaplasique à grandes cellules . Med Sci (Paris). 2015; ; 31 : :841.–852.